Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Comparing Center-Based and Home-Based Autism Therapy in Young Children

Compares two behavioral therapy settings for social communication in young children with autism.

Plain-language title generated from the registry record
Registry title: Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism

Key facts

Where
Stanford, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 5 years old?

Source: NCT04899544, who can take part

Where in United States

  • Stanford University School of MedicineStanford, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Stanford University
Trial code
NCT04899544
Record updated
5 November 2026
Original description
The aim of this clinical trial is to compare the efficacy of a 16-week center-based Pivotal Response Treatment (PRT-C) versus home-based Pivotal Response Treatment (PRT-H) in targeting social communication deficits in young children with autism spectrum disorder (ASD) with significant language delay. The two groups will also be compared to a control group that consists of children who are receiving treatment as usual (TAU).Read full original descriptionShow less

Randomized Controlled Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism

The aim of this clinical trial is to compare the efficacy of a 16-week center-based Pivotal Response Treatment (PRT-C) versus home-based Pivotal Response Treatment (PRT-H) in targeting social communication deficits in young children with autism spectrum disorder (ASD) with significant language delay. The two groups will also be compared to a control group that consists of children who are receiving treatment as usual (TAU).

Inclusion: Diagnosis of Autism Spectrum Disorder (ASD) based on Autism Diagnostic Interview Revised (ADI-R), Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) or Childhood Autism Rating Scale, Second Edition (CARS-2), Diagnostic and Statistical Manual 5th Edition (DSM-5), and expert clinical opinion; Boys and girls between 2.0 and 5.11 years; Ability to participate in the testing procedures to the extent that valid standard scores can be obtained; Language delay as measured by the Preschool Language Scale, 5th Edition (PLS-5): Standard score at least 1 standard deviation below average for expressive language ability for 2 and 3 year olds; 2 standard deviations for 4 year olds, and 3 standard deviations for 5 year olds; Stable treatment (e.g., Applied Behavior Analysis - ABA), speech therapy, school placement, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements; No anticipated changes on treatment during study participation for Center-Based Pivotal Response Treatment (PRT-C) and In-Home Pivotal Response Treatment (PRT-H); No more than 60 minutes of individual 1:1 speech therapy per week; Availability of at least one parent or primary caregiver who can consistently participate in parent training and research measures.

Exclusion: Receiving ABA of 15 hours or more; Previous adequate Pivotal Response Treatment (PRT) trial; Current or lifetime diagnosis of severe psychiatric disorder (e.g., bipolar disorder, etc.); Presence of active medical problem (e.g., unstable seizure disorder or heart disease); Participants living more than 30 miles from Stanford University; Child's primary language other than English.

ClinicalTrials.gov NCT04899544